Accessibility Menu
Grey Matters Health logo

Grey Matters Health(OTC) AGNPF

Market Cap$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-100%
5 Year-98%
1 Year-32%
1 Month+11%
$0.33
-1.27%
-0.00Today
Grey Matters Health last closing stock price
MetricPriceDate
Last closeUSD 0.332026-08-18
Grey Matters Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.04%USD 0.312026-08-07
1 month+10.97%USD 0.292026-07-17
3 month+14.18%USD 0.292026-05-19
Year to date-34.92%USD 0.502025-12-31
1 year-32.07%USD 0.482025-08-18
3 year-78.31%USD 1.502023-08-18
5 year-98.24%USD 18.532021-08-19
Since inception-99.78%USD 145.282016-03-11

Grey Matters Health Financials at a Glance

Market Cap

$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$2.46M

EPS (TTM)

-$0.38

P/E Ratio

-0.87

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.33

Volume

8

Open

$0.30

Previous Close

$0.33

Daily Range

$0.30 - $0.33

52-Week Range

$0.22 - $0.64

Estimated Earnings Date

Dec 18, 2026

AGNPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grey Matters Health

Grey Matters Health Inc. is a biotechnology company focused on drug re-purposing, investigating safe, already approved drugs for new disease applications. The company aims to develop new formulations and seek regulatory approvals in global markets, particularly for compounds not previously approved in the U.S. or Europe.

Products and Services
  • Drug re-purposing for new disease applications
  • Development of new formulations for existing drugs
  • Regulatory approval processes in global markets
Growth Outlook
  • Focus on innovative drug applications positions the company for future growth
  • Expanding research initiatives may lead to new market opportunities
  • Potential collaborations with healthcare partners could enhance development speed
Financial Highlights
  • Recent quarterly net income reported at -702,480 CAD
  • Operating expenses totaled 562,105 CAD in the latest quarter
  • Cash and cash equivalents decreased to 41,681 CAD as of May 31, 2026
Grey Matters Health Inc. operates in a niche market with a unique approach to drug development. The focus on re-purposing existing drugs allows for potentially lower research costs and faster time to market. The company's recent financial performance indicates challenges, with significant operating expenses and net losses. However, the strategic direction towards innovative drug applications and potential partnerships may provide avenues for future growth. Investors may find the company's commitment to exploring new therapeutic uses for established drugs an intriguing aspect of its business model.
AI Generated • Aug 4, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1

CEO

Chris Moreau

Website

www.algernonpharmaceuticals.com

Headquarters

Vancouver, BC V5Z 4C2, CA

AGNPF Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-124.45%

Return on Capital

-63.74%

Return on Assets

N/A

Earnings Yield

-1.15%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.92M

Volume

8

Avg. Volume

11.71K

Financials (TTM)

Gross Profit

-CA$158.38K

Operating Income

-CA$2.04M

EBITDA

-CA$1.43M

Operating Cash Flow

-CA$1.46M

Capital Expenditure

-CA$3.00

Free Cash Flow

-CA$1.46M

Cash & ST Invst.

CA$41.68K

Total Debt

CA$779.29K

Grey Matters Health Performance Analysis

Grey Matters Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31CAD 0N/A
20232023-08-31CAD 0N/A
20242024-08-31CAD 0N/A
20252025-08-31CAD 0N/A
Grey Matters Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-08-31N/A
Q12025-11-30N/A
Q22026-02-28N/A
Q32026-05-31N/A
Grey Matters Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31CAD -5.74-30.0%
20232023-08-31CAD -3.32-42.0%
20242024-08-31CAD -0.18-94.5%
20252025-08-31CAD -0.42126.2%
Grey Matters Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-08-3144.5%
Q12025-11-30-53.2%
Q22026-02-2835.3%
Q32026-05-31-18.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$54.22K

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$580.72K

N/A

Employees

5

N/A

Net Income

-CA$702.48K

-20.4%

EBITDA

-CA$507.88K

+11.6%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$41.68K

-52.7%

Total Debt

CA$779.29K

N/A

Accounts Receivable

CA$17.46K

+16.9%

Inventory

CA$0.00

N/A

Long Term Debt

CA$725.73K

N/A

Short Term Debt

CA$53.57K

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

-CA$145.01K

+16.9%

Operating Cash Flow

-CA$145.01K

+16.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZLDAFZelira Therapeutics Limited
$0.26+0.00%
HESGHealth Sciences Group, Inc.
$0.00+0.00%
APLIFAppili Therapeutics Inc
$0.01+0.00%
VGLSSB Technology Holdings Inc.
$0.22+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MRNAModerna
$141.90+1.25%
IBITiShares Bitcoin Trust
$38.59+0.05%
BITOProShares Trust - ProShares Bitcoin ETF
$9.21+0.05%
INTCIntel
$93.23-0.04%

Questions About AGNPF

What is the current price of Grey Matters Health?

Grey Matters Health is trading at $0.33 per share.

What is the 52-week range for Grey Matters Health?

Over the past 52 weeks, Grey Matters Health has traded between $0.22 and $0.64.

How much debt does Grey Matters Health have?

As of the most recent reporting period, Grey Matters Health reported total debt of CA$565.35K.

How much cash does Grey Matters Health have on hand?

Grey Matters Health reported CA$30.24K in cash and cash equivalents in its most recent financial results.

What is Grey Matters Health’s dividend yield?

Grey Matters Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services